Halozyme Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $15M | 415k | 36.96 |
| 2023-09-30 | $7.2M | 188k | 38.20 |
| 2023-06-30 | $7.4M | 205k | 36.07 |
| 2023-03-31 | $6.8M | 179k | 38.19 |
| 2022-12-31 | $8.4M | 147k | 56.90 |
| 2022-09-30 | $1.9M | 49k | 39.53 |
| 2022-06-30 | $3.5M | 79k | 44.01 |
| 2022-03-31 | $3.6M | 91k | 39.88 |
| 2021-12-31 | $7.1M | 176k | 40.21 |
| 2021-09-30 | $6.6M | 163k | 40.68 |
| 2021-06-30 | $3.8M | 83k | 45.40 |
| 2021-03-31 | $6.7M | 162k | 41.69 |
| 2020-12-31 | $4.6M | 108k | 42.71 |
| 2020-09-30 | $1.8M | 70k | 26.29 |
| 2020-06-30 | $9.4M | 351k | 26.80 |
| 2020-03-31 | $2.3M | 128k | 17.99 |
| 2019-12-31 | $4.8M | 269k | 17.73 |
| 2019-09-30 | $3.4M | 216k | 15.51 |
| 2019-06-30 | $2.3M | 135k | 17.18 |
| 2019-03-31 | $1.3M | 82k | 16.09 |
| 2018-12-31 | $3.0M | 203k | 14.63 |
| 2018-09-30 | $1.8M | 98k | 18.18 |
| 2018-06-30 | $1.1M | 67k | 16.70 |
| 2018-03-31 | $3.6M | 184k | 19.58 |
| 2017-12-31 | $1.7M | 83k | 20.32 |
| 2017-09-30 | $2.0M | 113k | 17.37 |
| 2017-06-30 | $1.2M | 92k | 12.82 |
| 2017-03-31 | $1.3M | 104k | 12.96 |
| 2016-12-31 | $1.9M | 195k | 9.88 |
| 2016-09-30 | $1.3M | 107k | 12.08 |
| 2016-06-30 | $1.9M | 222k | 8.57 |
| 2016-03-31 | $3.5M | 364k | 9.52 |
| 2015-12-31 | $5.3M | 308k | 17.33 |
| 2015-09-30 | $1.8M | 133k | 13.43 |
| 2015-03-31 | $5.1M | 354k | 14.29 |